Acadia Pharmaceuticals Inc (ACAD)
R&D Expenses
$81.56M
Quarterly · Period ending: · USD
ACAD R&D Expenses
Latest reported$81.56Mperiod ending
Latest reported$81.56Mperiod ending
ACAD Quarterly R&D Expenses ($4.13M → $81.56M)
Quarterly R&D Expenses
High-resolution chart · PNG
ACAD r&d expenses history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expenses (USD) |
|---|---|
| 81,555,000 | |
| 76,868,000 | |
| 84,757,000 | |
| 87,829,000 | |
| 77,951,000 | |
| 78,265,000 | |
| 100,731,000 | |
| 66,606,000 | |
| 76,233,000 | |
| 59,679,000 | |
| 66,741,000 | |
| 156,963,000 | |
| 58,771,000 | |
| 69,144,000 | |
| 75,738,000 | |
| 81,336,000 | |
| 75,646,000 | |
| 128,855,000 | |
| 66,942,000 | |
| 58,565,000 | |
| 56,935,000 | |
| 56,973,000 | |
| 62,116,000 | |
| 120,083,000 | |
| 64,295,000 | |
| 72,636,000 | |
| 57,520,000 | |
| 62,622,000 | |
| 67,320,000 | |
| 52,923,000 | |
| 48,183,000 | |
| 53,112,000 | |
| 46,592,000 | |
| 39,276,000 | |
| 43,179,000 | |
| 36,421,000 | |
| 34,180,000 | |
| 35,409,000 | |
| 30,218,000 | |
| 25,813,000 | |
| 20,478,000 | |
| 22,775,000 | |
| 20,466,000 | |
| 18,729,000 | |
| 18,379,000 | |
| 16,295,000 | |
| 18,182,000 | |
| 16,952,000 | |
| 13,799,000 | |
| 11,668,000 | |
| 7,925,000 | |
| 7,254,000 | |
| 7,112,000 | |
| 4,430,000 | |
| 4,901,000 | |
| 4,400,000 | |
| 4,472,000 | |
| 5,021,000 | |
| 4,424,000 | |
| 4,158,000 | |
| 4,315,000 | |
| 4,412,000 | |
| 4,757,000 | |
| 4,965,000 | |
| 5,041,000 | |
| 5,815,000 | |
| 7,836,000 | |
| 9,215,000 | |
| 11,979,000 | |
| 12,554,000 | |
| 12,146,000 | |
| 13,397,000 | |
| 16,036,000 | |
| 15,171,000 | |
| 17,278,000 | |
| 16,909,000 | |
| 11,495,000 | |
| 12,261,000 | |
| 10,919,000 | |
| 16,099,000 | |
| 12,255,000 | |
| 10,126,000 | |
| 10,104,300 | |
| 8,064,900 | |
| 6,563,100 | |
| 6,115,600 | |
| 6,374,900 | |
| 5,923,200 | |
| 5,406,600 | |
| 5,749,300 | |
| 0 | |
| 0 | |
| 4,323,600 | |
| 4,130,700 |